KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Non-Current Liabilities (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Other Non-Current Liabilities data on record, last reported at $56.5 million in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 27.48% year-over-year to $56.5 million; the TTM value through Dec 2025 reached $56.5 million, up 27.48%, while the annual FY2025 figure was $56.5 million, 27.48% up from the prior year.
  • Other Non-Current Liabilities reached $56.5 million in Q4 2025 per IDXX's latest filing, down from $57.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $85.0 million in Q2 2021 and bottomed at $44.3 million in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $65.0 million, with a median of $65.9 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 32.33% in 2024, then increased 27.48% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $70.9 million in 2021, then dropped by 4.73% to $67.6 million in 2022, then dropped by 3.05% to $65.5 million in 2023, then plummeted by 32.33% to $44.3 million in 2024, then rose by 27.48% to $56.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $56.5 million in Q4 2025, $57.6 million in Q3 2025, and $56.8 million in Q2 2025.